Literature DB >> 9498379

The risk of nephrectomy during local control in abdominal neuroblastoma.

R C Shamberger1, E I Smith, V V Joshi, P V Rao, F A Hayes, L C Bowman, R P Castleberry.   

Abstract

METHODS: Eight hundred sixty-eight children presenting from 1981 to 1991 were treated on five multiagent chemotherapy protocols by members of the Pediatric Oncology Group for advanced-stage neuroblastoma with large primary tumors crossing the midline or distant metastasis. Of these children, 696 had abdominal (adrenal or paravertebral) primary tumors. One hundred sixteen children underwent greater than 50% surgical resection of these abdominal primary tumors before chemotherapy, and 233 underwent similar surgery after induction chemotherapy.
RESULTS: Among the 349 who underwent surgical resection, 52 children (14.9%) had nephrectomy or renal infarction during surgery for local control. There was a 25% incidence among those with initial resection (29 patients) and a 9.9% incidence in the postchemotherapy resections (23 patients). Reasons for nephrectomy given by the surgeons included direct involvement of the kidney by adjacent tumor (17 children), clinical impression that the tumor was a Wilms' tumor (11 children), renal vessels could not be separated from the tumor (10 children), extensive tumor surrounding the kidney (8 children), postoperative renal infarction (4 children), marked decrease in unilateral renal function after chemotherapy (1 child), and position of the tumor posterior to the kidney and vena cava making resection without nephrectomy impossible (1 child). Of the patients undergoing nephrectomy, four children had an upper pole nephrectomy in conjunction with their adrenalectomy and resection of the tumor. Pathological review of the resected tumor available in 47 cases demonstrated direct involvement of the renal parenchyma in 18 cases (38% of the nephrectomies) and in 5.2% of those undergoing resection. In children undergoing initial resection, the risk for nephrectomy (as calculated by the methods described by Gart) was more than twice compared with those undergoing resection after chemotherapy (P = .012; odds ratio, 2.32; 95% confidence interval of 1.23 to 4.42).
CONCLUSIONS: This review confirms that renal parenchymal involvement does occur in a significant number of children with abdominal neuroblastoma. It also suggests that preoperative chemotherapy may decrease the number of nephrectomies required to achieve a total or subtotal resection.

Entities:  

Mesh:

Year:  1998        PMID: 9498379     DOI: 10.1016/s0022-3468(98)90424-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Successful treatment of infants with localized neuroblastoma based on their MYCN status.

Authors:  Tomoko Iehara; Minoru Hamazaki; Tatsuro Tajiri; Yoshifumi Kawano; Michio Kaneko; Hitoshi Ikeda; Hajime Hosoi; Tohru Sugimoto; Tadashi Sawada
Journal:  Int J Clin Oncol       Date:  2012-03-02       Impact factor: 3.402

2.  Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection.

Authors:  Irene Isabel P Lim; Debra A Goldman; Benjamin A Farber; Jennifer M Murphy; Sara J Abramson; Ellen Basu; Stephen Roberts; Michael P LaQuaglia; Anita P Price
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

3.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

Review 4.  A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.

Authors:  Alan M Chen; Andrew T Trout; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2018-08-04

5.  The role of complete surgical resection in stage IV neuroblastoma.

Authors:  Patrick J Bastian; Gudrun Fleischhack; Martina Zimmermann; Carola Hasan; Udo Bode; Stefan C Müller; Stefan Schumacher
Journal:  World J Urol       Date:  2004-09-14       Impact factor: 4.226

6.  Avoiding misdiagnosing neuroblastoma as Wilms tumor.

Authors:  Paxton V Dickson; Thomas L Sims; Christian J Streck; M Beth McCarville; Victor M Santana; Lisa M McGregor; Wayne L Furman; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.